Literature DB >> 16510005

Willingness to participate in HIV vaccine research in a peri-urban South African community.

J Smit1, K Middelkoop, L Myer, S Seedat, L-G Bekker, D J Stein.   

Abstract

Research on willingness to participate in HIV vaccine trials is important in preparations for HIV vaccine research, but there are few data from sub-Saharan Africa. We interviewed 198 individuals in a peri-urban South African community immediately after enrolment into an HIV vaccine preparedness study on their willingness to participate in hypothetical vaccine trials. Overall 23% of participants (n = 46) said that they would be willing to participate in an HIV vaccine trial. Willingness was associated with increasing age, male gender, and increasing knowledge about vaccines generally and HIV vaccines specifically. In multivariate analysis, a 1-unit increase in HIV vaccine knowledge score was associated with a 10-fold increase in willingness to participate (adjusted odds ratio, 10.72, 95% confidence intervals: 4.40-26.12). These results suggest that while willingness to participate in HIV vaccine trials is relatively low in this setting, educational campaigns may have a substantial impact on individuals' willingness to participate in research.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16510005     DOI: 10.1258/095646206775809259

Source DB:  PubMed          Journal:  Int J STD AIDS        ISSN: 0956-4624            Impact factor:   1.359


  8 in total

1.  Factors influencing mothers' decision to enroll their HIV-negative children in a hypothetical HIV vaccine trial.

Authors:  Victoria Williamson; Bronwyne Coetzee; Ashraf Kagee; Mark Tomlinson
Journal:  Future Virol       Date:  2016-12-21       Impact factor: 1.831

2.  Willingness to participate in biomedical HIV prevention studies after the HVTN 503/Phambili trial: a survey conducted among adolescents in Soweto, South Africa.

Authors:  Kennedy N Otwombe; Kathleen J Sikkema; Janan Dietrich; Guy de Bruyn; Martin van der Watt; Glenda E Gray
Journal:  J Acquir Immune Defic Syndr       Date:  2011-10-01       Impact factor: 3.731

3.  Cognitive factors and willingness to participate in an HIV vaccine trial among HIV-positive injection drug users.

Authors:  Shayesta Dhalla; Gary Poole; Joel Singer; David M Patrick; Thomas Kerr
Journal:  Psychol Health Med       Date:  2012-01-17       Impact factor: 2.423

4.  HIV infection awareness and willingness to participate in future HIV vaccine trials across different risk groups in Abuja, Nigeria.

Authors:  Gambo Aliyu; Mukhtar Mohammad; Ahmed Saidu; Prosanta Mondal; Man Charurat; Alash'le Abimiku; Abdulsalami Nasidi; William Blattner
Journal:  AIDS Care       Date:  2010-10

5.  Future HIV vaccine acceptability among young adults in South Africa.

Authors:  Jennifer N Sayles; Catherine L Macphail; Peter A Newman; William E Cunningham
Journal:  Health Educ Behav       Date:  2009-06-09

6.  Uptake of genital mucosal sampling in HVTN 097, a phase 1b HIV vaccine trial in South Africa.

Authors:  Erica Maxine Lazarus; Kennedy Otwombe; Tania Adonis; Elaine Sebastian; Glenda Gray; Nicole Grunenberg; Surita Roux; Gavin Churchyard; Craig Innes; Fatima Laher
Journal:  PLoS One       Date:  2014-11-17       Impact factor: 3.240

7.  Community Willingness to Participate in a Dengue Study in Aceh Province, Indonesia.

Authors:  Harapan Harapan; Samsul Anwar; Aslam Bustaman; Arsil Radiansyah; Pradiba Angraini; Riny Fasli; Salwiyadi Salwiyadi; Reza Akbar Bastian; Ade Oktiviyari; Imaduddin Akmal; Muhammad Iqbalamin; Jamalul Adil; Fenni Henrizal; Darmayanti Darmayanti; Rovy Pratama; Jonny Karunia Fajar; Abdul Malik Setiawan; Allison Imrie; Ulrich Kuch; David Alexander Groneberg; R Tedjo Sasmono; Meghnath Dhimal; Ruth Müller
Journal:  PLoS One       Date:  2016-07-12       Impact factor: 3.240

8.  The willingness to participate in biomedical research involving human beings in low- and middle-income countries: a systematic review.

Authors:  Joyce L Browne; Connie O Rees; Johannes J M van Delden; Irene Agyepong; Diederick E Grobbee; Ama Edwin; Kerstin Klipstein-Grobusch; Rieke van der Graaf
Journal:  Trop Med Int Health       Date:  2019-01-08       Impact factor: 2.622

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.